DU176b-D-U312. A phase 3, open label, randomized, multicenter, controlled trial to evaluate the pharmacokinetics of edobaxan and to compare the efficacy and safety of edobaxan with standart of care anticoagülant therapy in pediatric subjects from birth to less than 18 years of age with confirmed venous tromboembolism | AVESİS

İstanbul Üniversitesi Akademik Veri Yönetim Sistemi

DU176b-D-U312. A phase 3, open label, randomized, multicenter, controlled trial to evaluate the pharmacokinetics of edobaxan and to compare the efficacy and safety of edobaxan with standart of care anticoagülant therapy in pediatric subjects from birth to less than 18 years of age with confirmed venous tromboembolism

Karakaş Z. (Yürütücü), Karaman S.

Diğer Uluslararası Fon Programları, 2017 - 2022

Proje Türü: Diğer Uluslararası Fon Programları
Başlama Tarihi: Nisan 2017
Bitiş Tarihi: Ağustos 2022

Proje Özeti

DU176b-D-U312. A phase 3, open label, randomized, multicenter, controlled trial to evaluate the pharmacokinetics of edobaxan and to compare the efficacy and safety of edobaxan with standart of care anticoagülant therapy in pediatric subjects from birth to less than 18 years of age with confirmed venous tromboembolism